The Social Health Authority (SHA) will now fully cover the cost of a vital cancer therapy for breast and gastric cancers in Kenya, following a new deal between the Ministry of Health and Roche Pharmaceuticals. This partnership has dramatically reduced the per-session treatment cost from Sh120,000 to Sh40,000, with SHA covering the full amount for patients without copayment.

• The cost of a key cancer therapy session has been reduced from Sh120,000 to Sh40,000.
• The deal was formed between the Ministry of Health and Roche Pharmaceuticals, with Health Cabinet Secretary Aden Duale announcing the initiative.
• Over 70% of cancer cases in Kenya are diagnosed at late stages, highlighting a critical need for expanded early detection and diagnostic services.